ReViral Appoints Alex C. Sapir as CEO ReViral Ltd., a clinical-stage company focused on developing novel, antiviral compounds that target respiratory syncytial virus (RSV), today announced that Alex C. Sapir has been … more ➔
Paul Hudson to become Sanofi CEO At its meeting on June 6th of 2019, Sanofi’s Board of Directors unanimously appointed Paul Hudson as Chief Executive Officer of the Group, to succeed Olivier Brandicourt who has decided to ret … more ➔
Dietmar Berger returns to big pharma Sanofi has a new head of development, which the company confirmed on Wednesday with a short tweet: "Dietmar Berger, MD, PhD, joins #Sanofi as Head of Development, overseeing our clinical portfolio … more ➔
Biotage gets new CEO Tomas Blomquist has been appointed as the new CEO and President of Biotage AB. more ➔
Affimed parts with CSO Dr. Martin Treder has informed Affimed that he intends to step down from his position as Chief Scientific Officer to pursue new opportunities. more ➔
Mark Hammond joins PBD Biotech Novel diagnostic developer PBD Biotech announces the appointment of new CEO Mark Hammond to drive the company’s expansion. more ➔
Mogrify appoints new CBO and COO Mogrify appoints 15 new staff including, Dr Karin Schmitt as Chief Business Officer and Joe Foster as Chief Operating Officer more ➔
Bionure appoints Dr. Lucia Septien as CMO Bionure, a biotech company specialized in neuroprotection, today announces that it has appointed Dr. Lucia Septien as chief medical officer. more ➔
Immunocore appoints Mohammed DarImmunocore has appointed Dr Mohammed Dar as Head of Clinical Development and Chief Medical Officer. Mohammed Dar will lead the continued clinical development of tebentafusp(IMCgp100) and other key programmes … more ➔
Dr Stuart Quin appointed as CEO of Medic...Medica Group Plc (LSE:MGP) announces that Dr Stuart Quin has been appointed as Chief Executive Officer. Dr Quin will join Medica and its Board of Directors on 1 September 2019. John Graham will remain … more ➔
